ProfileGDS4132 / 1559093_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 25% 26% 34% 29% 24% 25% 23% 25% 23% 34% 28% 25% 29% 32% 38% 27% 39% 27% 29% 31% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10160.085125
GSM201543Muscle PCOS pioglitazone 12153.620826
GSM201544Muscle PCOS pioglitazone 16187.677534
GSM201545Muscle PCOS pioglitazone 20177.663729
GSM201829Muscle PCOS pioglitazone 23160.858724
GSM201830Muscle PCOS pioglitazon 25160.072525
GSM201831Muscle PCOS pioglitazone 27151.104623
GSM201832Muscle PCOS pioglitazone 3159.169125
GSM201833Muscle PCOS pioglitazone 4149.346823
GSM201834Muscle PCOS pioglitazone 8182.300734
GSM201835Muscle PCOS after pioglitazone 10254.319528
GSM201836Muscle PCOS after pioglitazone 12250.308225
GSM201837Muscle PCOS after pioglitazone 16257.404229
GSM201838Muscle PCOS after pioglitazone 20271.587332
GSM201839Muscle PCOS after pioglitazone 23290.96938
GSM201840Muscle PCOS after pioglitazone 25262.57827
GSM201841Muscle PCOS after pioglitazone 27286.050639
GSM201842Muscle PCOS after pioglitazone 3252.026727
GSM201843Muscle PCOS after pioglitazone 4269.432829
GSM201844Muscle PCOS after pioglitazone 8271.932131